Paul Nouri, CFP
Hedge fund manager, long/short equity, healthcare

Trinity Biotech: One Of The Most Inexpensive Names In Med-Tech With Catalysts

Trinity Biotech (NASDAQ:TRIB) is one of the few names remaining in the Med-Tech space that's not only reasonably priced, but has a number of catalysts coming up over the next 12-18 months.

For those who are not familiar with the name, Trinity Biotech is a diagnostic company which attains a substantial portion of its revenue from point-of-care diagnostics and clinical diagnostics systems. As you can see from the table below, the company has grown revenue for each of the past two years, albeit at a mid single digit rate.

2010 2011 2012
Point of Care $16m $17m $19m
Clinical Diagnostic Systems 45m 50m 54m
Life Science Supply 12m 11m 10m
Total 73m 78m 83m

Business Segments



Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details